# Ketamine Efficacy for Acute Severe Bronchospasm in ICU: MACANUDO Trial

> **NCT03000413** · PHASE2,PHASE3 · COMPLETED · sponsor: **Hospital Nossa Senhora da Conceicao** · enrollment: 45 (actual)

## Conditions studied

- Critical Illness
- Asthma
- Bronchospasm

## Interventions

- **DRUG:** Ketamine
- **DRUG:** Fentanyl

## Key facts

- **NCT ID:** NCT03000413
- **Lead sponsor:** Hospital Nossa Senhora da Conceicao
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06-04
- **Primary completion:** 2017-06-16
- **Final completion:** 2018-01-29
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2024-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03000413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03000413, "Ketamine Efficacy for Acute Severe Bronchospasm in ICU: MACANUDO Trial". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT03000413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*